Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Hongxue Yuan
Sinovac (Dalian) Vaccine Technology Co., Ltd.
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
32
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Immunogenicity and Safety of a Live-Attenuated Varicella Vaccine in a Healthy Population Aged 13 Years and Older: A Randomized, Double-Blind, Controlled Study
Number of pages: 17
Posted: 25 May 2023
Lili Huang
,
Zhen Chen
,
Yufei Song
,
Jiebing Tan
,
Ningning Jia
,
Wangyang You
, Hongxue Yuan,
Guang-Wei Feng
,
Changgui Li
,
Chunfang Luan
,
Yaru Quan
and
Yanxia Wang
Henan Provincial Center for Disease Control Prevention, Government of the People's Republic of China - National Institutes for Food and Drug Control, Sinovac Biotech CO., Ltd., Henan Provincial Center for Disease Control Prevention, Sinovac Biotech CO., Ltd., Henan Provincial Center for Disease Control Prevention, Sinovac (Dalian) Vaccine Technology Co., Ltd., Henan Provincial Center for Disease Control Prevention, National Institutes for Food and Drug Control, Government of the People's Republic of China - National Institutes for Food and Drug Control, Government of the People's Republic of China - National Institutes for Food and Drug Control and Government of the People's Republic of China - National Institutes for Food and Drug Control
Downloads
32
(1,304,549)
View PDF
Download
Abstract:
live-attenuated varicella vaccine, immunogenicity, safety, two-dose immunization schedule
Feedback
